Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI)

CUSIP: 89532M101

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-551,621
Put/Call ratio
27%
SEC-reported price per share
$3.45
Number of holders
79
Value change
-$90,828
Number of buys
37
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
143,562,667

Security key

89532M101

Report period

Q1 2024

Institutions

79

Top holders

10

Ownership snapshot

Top reported holders of TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
NEA Management Company, LLC
Disclosed value leader
NEA Management Company, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F Lead comparable stake: 7.9% Showing 1-6 of 15 holder rows.

Quick read

NEA Management Company, LLC leads the comparable SEC ownership view at 7.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NEA Management Company, LLC's linked filing trail.
Comparable ownership Top 5
NEA Management Company, LLC 7.9%
Frazier Life Sciences Management,... 5.1%
Rubric Capital Management LP 4%
VIKING GLOBAL INVESTORS LP 3.1%
Venrock Adviser, LLC 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
NEA Management Company, LLC
13F
Company
13F
7.9%
$15,236,304
11,370,376 shares
31 Dec 2023
Frazier Life Sciences Management, L.P.
13F
Company
13F
5.1%
$9,890,661
7,381,090 shares
31 Dec 2023
Rubric Capital Management LP
13F
Company
13F
4%
$7,617,123
5,684,420 shares
31 Dec 2023
VIKING GLOBAL INVESTORS LP
13F
Company
13F
3.1%
$5,896,000
4,400,000 shares
31 Dec 2023
Venrock Adviser, LLC
13F
Company
13F
2.4%
$4,586,012
3,422,397 shares
31 Dec 2023
Opaleye Management Inc.
13F
Company
13F
1.8%
$3,396,900
2,535,000 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
79
Shares
51,561,502
Rows available
79
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
62
Q1 2024 holders
79
Holder diff
17
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .